Physicians at Fox Chase Cancer Center have achieved a significant milestone by performing 10,000 surgeries using the da Vinci robotic surgical system. This technology has played a crucial role in providing advanced treatment options for cancer patients across various specialties.
“The da Vinci system has been transformative in the surgical space at Fox Chase,” said an unnamed Chair of the center. “Reaching 10,000 surgeries shows just how versatile this technology is and how robotic surgery is opening the door for so many more cancer patients to experience better outcomes and minimally invasive surgical procedures.”
The da Vinci system is utilized at Fox Chase for a range of complex surgeries, including those related to urologic, gynecologic, colorectal, esophagus, stomach, liver, pancreas, lung, and head and neck cancers. “The majority of our colon and rectal surgeries are now done robotically, as well as gastrectomies for stomach cancer, complex liver and pancreas surgery, esophagectomies, lung resections, and many gynecologic surgeries,” stated Farma.
Robotic surgery allows for complicated operations with smaller incisions. Studies have shown that since its introduction in 2000, the da Vinci system has revolutionized minimally invasive surgery by enhancing visualization and precision. Patients generally experience quicker recovery times and shorter hospital stays compared to traditional open surgery.
The system provides computer and robotic assistance with magnified high-definition 3D views. Wristed instruments mimic the surgeon’s hand movements while high-definition cameras aid in precise dissection and reconstruction within the body. “With the use of this technology, surgeons have improved visualization and can expand minimally invasive options for cancer patients,” Farma added.
Fox Chase Cancer Center’s faculty are national leaders in robotic-assisted surgery. The center incorporates robotic surgery into its training programs to prepare future surgeons through fellowships such as Complex General Surgical Oncology Fellowship and others focused on thoracic surgical oncology, gynecologic oncology, urologic oncology, reconstructive urology.
“We have really been on the forefront of being able to do a vast majority of oncologic cases for all specialties using this robotic technique,” said Farma. “Our extensive experience with these surgeries has positioned us as leaders in this field.”
